Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032
Overview
The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is expected to reach a 91.49 USD Million by 2032 and is projected to grow at a CAGR of 23.80% from 2025 to 2032.
Revenue, 2024 (USD Million)
25.98
Forecast, 2032 (USD Million)
91.49
CAGR, 2024 - 2032
23.80%
Report Coverage
Thailand
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 2018-2032 USD Million
Thailand Duchenne Muscular Dystrophy Treatment Market 2030, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 25.98 USD Million
- Projected Market Size (2032): 91.49 USD Million
- CAGR (2025-2032): 23.80%
Key Findings of Thailand Duchenne Muscular Dystrophy Treatment Market 2030
- The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 was valued at 25.98 USD Million in 2024.
- The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is likely to grow at a CAGR of 23.80% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Parenteral in Route of Administration Segment accounted for the largest share of the market with a revenue of 20.35 USD Million
- The fastest growing segment Steroid Therapy in Treatment Segment grew Fastest with a CAGR of 24.40% during the forecast period from 2024 to 2032.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Scope
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Therapy
- Dystrophin-Targeted Therapies
- Mutation Suppression
- Exon Skipping Approach
Route of Administration
- Others
- Oral
- Parenteral
Treatment
- Others
- Steroid Therapy
- Molecular-Based Therapies
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 25.98 USD Million |
| Market Value in 2032 | 91.49 USD Million |
| CAGR (2025-2032) | 23.80% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Therapy,Route of Administration ,Treatment |
Regional Insights:
-
Leading Market (2024-2032): Thailand, leading in terms of revenue 25.98 USD Million in 2024
- Key Country: Thailand, leading in terms of revenue with value of 25.98 USD Million in 2024.
Segments and Scope
-
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 17.91 USD Million in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 24.24 % in forecast period 2025-2032.
-
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By End User
- Hospitals is the largest segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 16.32 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 24.20 % in forecast period 2025-2032.
-
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Therapy
- Exon Skipping Approach is the largest segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 16.33 USD Million in the year 2024.
- Exon Skipping Approach is the Fastest growing segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 24.15 % in forecast period 2025-2032.
-
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Route of Administration
- Parenteral is the largest segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 20.35 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 24.33 % in forecast period 2025-2032.
-
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032, By Treatment
- Molecular-Based Therapies is the largest segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a revenue of 13.70 USD Million in the year 2024.
- Steroid Therapy is the Fastest growing segment in Thailand Duchenne Muscular Dystrophy Treatment Market 2030 to 2032 with a Growth rate of 23.74 % in forecast period 2025-2032.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Company Share Analysis
| Company Name |
|
||
| Pfizer Inc. | |||
| F. Hoffmann-La Roche Ltd. | |||
| PTC Therapeutics. | |||
| Sarepta Therapeutics, Inc. | |||
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Geographical Sales Distribution, 2018-2032 USD Million
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Industry Related Reports
Frequently Asked Questions
The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Therapy,Route of Administration ,Treatment.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 25.98(Revenue in USD Million) in 2021.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 23.80% during the forecast period of 2024 to 2032.
The Parenteral segment is expected to dominate the Thailand Duchenne Muscular Dystrophy Treatment Market 2030, holding a largest market share of 20.35 USD Million in 2024
Coming Soon....
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Scope
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Segmentation & Scope
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
End User
- Others
- Homecare
- Specialty Clinics
- Hospitals
Therapy
- Dystrophin-Targeted Therapies
- Mutation Suppression
- Exon Skipping Approach
Route of Administration
- Others
- Oral
- Parenteral
Treatment
- Others
- Steroid Therapy
- Molecular-Based Therapies
Frequently Asked Questions
The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Therapy,Route of Administration ,Treatment.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 25.98(Revenue in USD Million) in 2021.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 23.80% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 91.49 (USD Million).
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 Company Profiling
Frequently Asked Questions
The Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is segmented based on Segmentation Distribution Channel,End User,Therapy,Route of Administration ,Treatment.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 was valued at USD 25.98(Revenue in USD Million) in 2021.
Thailand Duchenne Muscular Dystrophy Treatment Market 2030 is projected to grow at a CAGR of 23.80% during the forecast period of 2024 to 2032.
The estimated market value of the Thailand Duchenne Muscular Dystrophy Treatment Market 2030 for final year is USD 91.49 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.